GO:0061756 leukocyte adhesion to vascular endothelial cell: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0061756 describes the attachment of a leukocyte to a vascular endothelial cell via adhesion molecules, a critical early step in inflammation and immune surveillance.
• The process is driven by sequential interactions between endothelial selectins, integrins, and immunoglobulin superfamily adhesion molecules such as ICAM-1 and VCAM-1.
• Endothelial cell activation by cytokines, oxidative stress, or metabolic signals upregulates adhesion molecules and promotes leukocyte attachment.
• Dysregulated leukocyte adhesion contributes to sepsis, liver fibrosis, neuroinflammation, and cardiovascular disease.
• Key experimental models include endothelial cell-leukocyte co-culture adhesion assays, flow chamber systems, and CRISPR-engineered endothelial cell lines.
• Targeting adhesion molecules or signaling pathways (e.g., p38 MAPK, NF-kB) reduces leukocyte attachment and vascular inflammation in preclinical models.
Description
Leukocyte adhesion to vascular endothelial cells (GO:0061756) is a fundamental biological process in which circulating leukocytes attach to the endothelial lining of blood vessels through specific adhesion molecules. This interaction is essential for immune cell recruitment to sites of infection, injury, and inflammation, and it represents a tightly regulated checkpoint in the inflammatory cascade. The process is initiated by selectin-mediated tethering and rolling, followed by integrin activation and firm adhesion to immunoglobulin superfamily ligands such as ICAM-1 and VCAM-1 on the endothelial surface. Researchers study GO:0061756 to understand how immune cells navigate the vasculature and to identify therapeutic targets for inflammatory and vascular diseases. Dysregulation of leukocyte adhesion is implicated in a wide range of pathologies, including sepsis, acute inflammation, liver fibrosis, and neuroinflammatory conditions. Because the process is orchestrated by a defined set of adhesion molecules and signaling pathways, it is highly amenable to genetic and pharmacological interrogation using CRISPR-based models and endothelial-leukocyte adhesion assays.
leukocyte adhesion to vascular endothelial cell At A Glance
| GO ID | GO:0061756 |
|---|---|
| GO term | leukocyte adhesion to vascular endothelial cell |
| Ontology | biological_process |
| Synonym | none |
| Definition | The attachment of a leukocyte to vascular endothelial cell via adhesion molecules. |
| Major function | Mediates the initial firm attachment of leukocytes to the endothelium during inflammation and immune surveillance. |
| Key adhesion molecules | ICAM-1, VCAM-1, selectins, integrins (e.g., LFA-1, VLA-4). |
| Regulatory pathways | p38 MAPK, NF-kB, insulin signaling, oxidative stress. |
| Associated diseases | Sepsis, liver fibrosis, neuroinflammation, cardiovascular disease. |
What Is GO:0061756?
According to the Gene Ontology, GO:0061756 (leukocyte adhesion to vascular endothelial cell) is defined as the attachment of a leukocyte to a vascular endothelial cell via adhesion molecules. This definition captures the physical binding event between a leukocyte and an endothelial cell, mediated by specific cell surface adhesion proteins, without specifying the subsequent signaling or transmigration steps.
Why Is leukocyte adhesion to vascular endothelial cell Important in Cell Biology?
Leukocyte adhesion to vascular endothelial cells is a rate-limiting step in the inflammatory response and immune cell trafficking. Understanding this process is essential for developing therapies that modulate inflammation without compromising host defense, and for elucidating how endothelial dysfunction contributes to disease.
• It is the first committed step in leukocyte recruitment to inflamed or injured tissues.
• It is required for immune surveillance and pathogen clearance.
• Dysregulation leads to excessive inflammation in sepsis and acute inflammatory conditions.
• It contributes to liver fibrosis through VCAM-1-mediated leukocyte adhesion in sinusoidal endothelium.
• It is implicated in neuroinflammation and cognitive impairment in Alzheimer's disease models.
• Endothelial insulin signaling regulates CXCR4 and limits leukocyte adhesion, linking metabolism to vascular inflammation.
• Pharmacological inhibition of p38 MAPK and NF-kB reduces adhesion molecule expression and leukocyte attachment.
• It is a target for anti-inflammatory therapies in cardiovascular and metabolic diseases.
• CRISPR-based genetic screens can identify novel regulators of this process.
• It serves as a model for studying cell-cell adhesion and signal transduction.
What Happens During leukocyte adhesion to vascular endothelial cell?
Endothelial activation and adhesion molecule upregulation
In simple terms: The endothelial cell gets activated and puts more sticky proteins on its surface.
In response to inflammatory cytokines, oxidative stress, or metabolic signals, vascular endothelial cells become activated and upregulate adhesion molecules such as ICAM-1, VCAM-1, and selectins. This upregulation is driven by signaling pathways including NF-kB and p38 MAPK, and is modulated by endothelial insulin signaling. The increased surface expression of these molecules is a prerequisite for leukocyte attachment.
Leukocyte tethering and rolling
In simple terms: The leukocyte slows down and rolls along the blood vessel wall.
Circulating leukocytes initially tether to and roll on the endothelial surface through interactions between leukocyte selectins and endothelial selectin ligands. This transient adhesion is mediated by selectins and their carbohydrate ligands, and allows the leukocyte to sample the local environment for chemokines and activating signals.
Integrin activation and firm adhesion
In simple terms: The leukocyte locks onto the vessel wall through stronger adhesion proteins.
Chemokine signaling activates leukocyte integrins such as LFA-1 and VLA-4, which then bind with high affinity to their endothelial ligands ICAM-1 and VCAM-1, respectively. This integrin-mediated firm adhesion is the defining event of GO:0061756 and is required for subsequent leukocyte transmigration. The interaction is tightly regulated to prevent inappropriate adhesion in healthy vessels.
Regulation by endothelial metabolism and signaling
In simple terms: The endothelial cell's internal metabolism and signaling control how sticky it becomes.
Endothelial cell metabolism, including glycolytic and oxidative pathways, influences adhesion molecule expression and leukocyte attachment. Insulin signaling in endothelial cells regulates CXCR4 and limits leukocyte adhesion, providing a link between systemic metabolism and vascular inflammation. Oxidative stress can promote endothelial dysfunction and enhance leukocyte adhesion.
Pathological amplification in disease
In simple terms: In disease, the adhesion process goes into overdrive and causes damage.
In conditions such as sepsis, liver fibrosis, and neuroinflammation, leukocyte adhesion to endothelial cells is pathologically amplified, leading to tissue damage. For example, VCAM-1 expressed on liver sinusoidal endothelial cells promotes leukocyte adhesion and liver fibrosis, and in Alzheimer's disease models, reducing VCAM-1 expression decreases leukocyte adhesion to brain vascular endothelial cells and alleviates cognitive impairment.
Key Genes Involved in GO:0061756 leukocyte adhesion to vascular endothelial cell
The following genes and proteins are central to leukocyte adhesion to vascular endothelial cells, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ICAM1 | Endothelial ligand for leukocyte integrins; mediates firm adhesion | Target for anti-inflammatory therapies; knockout reduces leukocyte adhesion |
| VCAM1 | Endothelial ligand for VLA-4; mediates leukocyte adhesion in inflammation and fibrosis | Knockout or knockdown reduces leukocyte adhesion in liver and brain |
| SELE | Endothelial selectin; mediates initial tethering and rolling | Target for blocking early adhesion events |
| SELP | Platelet/endothelial selectin; mediates leukocyte rolling | Studied in thrombosis and inflammation |
| ITGAL | Integrin alpha-L (LFA-1); binds ICAM-1 on endothelium | Knockout impairs firm adhesion |
| ITGB2 | Integrin beta-2; partner of LFA-1 | Mutations cause leukocyte adhesion deficiency |
| ITGA4 | Integrin alpha-4 (VLA-4); binds VCAM-1 | Target in multiple sclerosis and inflammatory bowel disease |
| CXCR4 | Chemokine receptor; regulated by insulin signaling in endothelium | Endothelial-specific knockout increases leukocyte adhesion |
| NFKB1 | Transcription factor driving adhesion molecule expression | Inhibition reduces ICAM-1 and VCAM-1 expression |
| MAPK14 | p38 MAPK alpha; regulates endothelial activation | Pharmacological inhibition reduces leukocyte attachment |
| INSR | Insulin receptor; regulates endothelial CXCR4 and adhesion | Endothelial-specific knockout alters leukocyte adhesion |
| NOS3 | Endothelial nitric oxide synthase; modulates vascular tone and adhesion | Dysfunction increases oxidative stress and adhesion |
| TNF | Pro-inflammatory cytokine; upregulates adhesion molecules | Stimulus for in vitro adhesion assays |
| IL1B | Pro-inflammatory cytokine; activates endothelium | Used to induce adhesion molecule expression |
| SELL | L-selectin; mediates leukocyte rolling | Knockout reduces rolling and adhesion |
| CD44 | Adhesion molecule involved in leukocyte recruitment | Studied in inflammation and cancer |
| PECAM1 | Platelet/endothelial cell adhesion molecule-1; involved in transmigration | Knockout affects leukocyte emigration |
| JAM-A | Junctional adhesion molecule-A; regulates leukocyte adhesion | Target for modulating endothelial permeability |
How Is leukocyte adhesion to vascular endothelial cell Regulated?
Leukocyte adhesion to vascular endothelial cells is regulated by a complex interplay of signaling pathways, including p38 MAPK and NF-kB, which control the expression of adhesion molecules such as ICAM-1 and VCAM-1. Endothelial insulin signaling regulates CXCR4 and limits leukocyte adhesion, linking metabolic status to vascular inflammation. Oxidative stress and endothelial dysfunction can enhance adhesion molecule expression and leukocyte attachment. Additionally, intracellular endothelial cell metabolism influences vascular function and adhesion. Pharmacological inhibition of p38 MAPK alpha and NF-kB signaling with compounds such as neflamapimod reduces endothelial cell activation, adhesion molecule expression, and leukocyte attachment.
leukocyte adhesion to vascular endothelial cell and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| VCAM1 | Liver fibrosis; neuroinflammation | Endothelial-specific knockout or knockdown in mouse models |
| ICAM1 | Sepsis; acute inflammation | ICAM1 knockout mice or endothelial cell lines |
| CXCR4 | Metabolic vascular inflammation | Endothelial-specific CXCR4 knockout mice |
| MAPK14 | Inflammatory vascular disease | p38 MAPK alpha inhibitor treatment or knockout |
| NFKB1 | Sepsis; inflammatory diseases | NF-kB inhibition in endothelial cells |
Sepsis and acute inflammation
In sepsis, the endothelial glycocalyx is degraded, leading to increased leukocyte adhesion and vascular dysfunction. Oxidative stress and endothelial dysfunction further promote leukocyte attachment, contributing to organ damage. Targeting adhesion molecules or their regulators is a potential therapeutic strategy in sepsis.
Liver fibrosis
Liver sinusoidal endothelial cells express VCAM-1, which promotes leukocyte adhesion and contributes to liver fibrosis. Blocking VCAM-1 or its interactions reduces leukocyte adhesion and may attenuate fibrosis progression.
Neuroinflammation and Alzheimer's disease
In Alzheimer's disease models, increased VCAM-1 expression on brain vascular endothelial cells enhances leukocyte adhesion, contributing to cognitive impairment and neuropathology. Reducing VCAM-1 expression or leukocyte adhesion alleviates these deficits.
Cardiovascular and metabolic disease
Endothelial insulin resistance and oxidative stress promote leukocyte adhesion, linking metabolic disorders to cardiovascular inflammation. Endothelial insulin signaling regulates CXCR4 and limits leukocyte adhesion, suggesting that insulin resistance exacerbates vascular inflammation.
From leukocyte adhesion to vascular endothelial cell-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate leukocyte adhesion to endothelial cells? | Endothelial-specific knockout of gene X in mice or CRISPR knockout in human endothelial cell lines |
| Does a point mutation in adhesion molecule Y alter binding affinity? | CRISPR point-mutation knock-in of the mutation in endothelial cells |
| Does tagging adhesion molecule Z with a fluorescent protein affect its localization? | CRISPR knock-in of a fluorescent tag at the endogenous locus |
| Does overexpression of gene W increase leukocyte adhesion? | Lentiviral or CRISPR-mediated overexpression in endothelial cells |
| Which genes are essential for leukocyte adhesion? | Genome-wide CRISPR knockout library screening in endothelial cells followed by adhesion assay |
| Does a disease-associated SNP in gene V affect adhesion? | CRISPR knock-in of the SNP in endothelial cells |
How to Study the leukocyte adhesion to vascular endothelial cell Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Static adhesion assay | Number of leukocytes adhering to endothelial monolayer | Screening for genes or drugs affecting adhesion |
| Flow chamber assay | Leukocyte rolling, adhesion, and transmigration under shear stress | Physiological studies of adhesion dynamics |
| CRISPR knockout screen | Genes required for leukocyte adhesion | Discovery of novel regulators |
| Flow cytometry | Surface expression of adhesion molecules (ICAM-1, VCAM-1) | Validation of endothelial activation |
| Western blot | Protein levels of adhesion molecules and signaling proteins | Mechanistic studies |
| qPCR | mRNA levels of adhesion molecules | Gene expression analysis |
| RNA-seq | Global transcriptional changes in endothelial cells | Pathway discovery |
| Proteomics | Protein abundance and modifications | Identification of novel adhesion regulators |
In vitro leukocyte adhesion assays
Leukocyte adhesion to endothelial cells is commonly measured by co-culturing fluorescently labeled leukocytes with activated endothelial monolayers and quantifying adherent cells. This assay can be combined with genetic perturbations to test the role of specific genes.
Flow chamber and microfluidic models
Flow chamber systems simulate physiological shear stress and allow real-time visualization of leukocyte rolling, adhesion, and transmigration on endothelial cells. These models provide more physiologically relevant data than static assays.
CRISPR screening and functional genomics
Genome-wide CRISPR knockout or activation screens in endothelial cells can identify novel regulators of leukocyte adhesion. Hits are validated using targeted knockout or overexpression followed by adhesion assays.
Protein and gene expression analysis
Adhesion molecule expression (e.g., ICAM-1, VCAM-1) is measured by flow cytometry, Western blot, or qPCR after cytokine stimulation or genetic manipulation. RNA-seq and proteomics can reveal global changes in endothelial cells during adhesion.
How CRISPR Can Be Used to Study GO:0061756 leukocyte adhesion to vascular endothelial cell
Knockout
CRISPR knockout of candidate genes in endothelial cells or mice is used to determine whether a gene is required for leukocyte adhesion. For example, endothelial-specific knockout of CXCR4 increases leukocyte adhesion, demonstrating its regulatory role.
Point Mutation
CRISPR point mutation can introduce specific amino acid changes in adhesion molecules to test their functional impact on leukocyte binding. This is useful for studying disease-associated variants in ICAM1 or VCAM1.
Knock-in
CRISPR knock-in of fluorescent tags or reporter genes at endogenous loci allows real-time tracking of adhesion molecule expression and localization in endothelial cells. Knock-in of disease-associated SNPs can model genetic susceptibility.
Overexpression
CRISPR activation or lentiviral overexpression of candidate genes in endothelial cells is used to test whether increased expression enhances leukocyte adhesion. This approach can validate gain-of-function mechanisms.
How EDITGENE Supports leukocyte adhesion to vascular endothelial cell Research
Researchers studying leukocyte adhesion to vascular endothelial cell-related genes often need to determine whether a candidate gene is causally involved in the adhesion process or is merely a bystander. EDITGENE provides a comprehensive suite of CRISPR-based services to enable precise genetic interrogation of this pathway in endothelial cells and animal models.
Contact EDITGENE today to design your custom CRISPR model for leukocyte adhesion to vascular endothelial cell research.
Frequently Asked Questions About leukocyte adhesion to vascular endothelial cell
What is GO:0061756?
GO:0061756 is the Gene Ontology term for leukocyte adhesion to vascular endothelial cell, defined as the attachment of a leukocyte to a vascular endothelial cell via adhesion molecules.
What genes are involved in leukocyte adhesion to vascular endothelial cell?
Key genes include ICAM1, VCAM1, SELE, SELP, ITGAL, ITGB2, ITGA4, CXCR4, and NFKB1, among others.
What diseases are associated with leukocyte adhesion to vascular endothelial cell?
Dysregulated leukocyte adhesion is associated with sepsis, liver fibrosis, neuroinflammation, and cardiovascular disease.
How is leukocyte adhesion to vascular endothelial cell studied?
It is studied using in vitro adhesion assays, flow chamber systems, CRISPR screens, and gene expression analysis.
What is the role of ICAM-1 in leukocyte adhesion?
ICAM-1 on endothelial cells binds to leukocyte integrins such as LFA-1 to mediate firm adhesion.
What is the role of VCAM-1 in leukocyte adhesion?
VCAM-1 binds to VLA-4 on leukocytes and is important in inflammation, liver fibrosis, and neuroinflammation.
How does oxidative stress affect leukocyte adhesion?
Oxidative stress promotes endothelial dysfunction and increases adhesion molecule expression, enhancing leukocyte adhesion.
Can CRISPR be used to study leukocyte adhesion?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to study genes involved in leukocyte adhesion.
What signaling pathways regulate leukocyte adhesion to endothelial cells?
p38 MAPK, NF-kB, and insulin signaling pathways regulate adhesion molecule expression and leukocyte attachment.
What is the clinical significance of leukocyte adhesion to vascular endothelial cell?
It is a therapeutic target for inflammatory and vascular diseases, and its modulation can reduce tissue damage.
Conclusion
Leukocyte adhesion to vascular endothelial cells (GO:0061756) is a central process in inflammation and immune surveillance, mediated by a well-defined set of adhesion molecules and signaling pathways. Dysregulation of this process contributes to sepsis, liver fibrosis, neuroinflammation, and cardiovascular disease, making it an attractive target for therapeutic intervention. Advances in CRISPR-based genetic models and functional assays are enabling researchers to dissect the molecular mechanisms of leukocyte adhesion with unprecedented precision. Continued research in this area promises to yield new strategies for treating inflammatory and vascular disorders.
References
- 1. Citrin KM et al.. 2025. Intracellular endothelial cell metabolism in vascular function and dysfunction.. Trends Endocrinol Metab 36(8):744-755 PMID: 39672762
- 2. Uchimido R et al.. 2019. The glycocalyx: a novel diagnostic and therapeutic target in sepsis.. Crit Care 23(1):16 PMID: 30654825
- 3. Joffre J et al.. 2021. Oxidative Stress and Endothelial Dysfunction in Sepsis and Acute Inflammation.. Antioxid Redox Signal 35(15):1291-1307 PMID: 33637016
- 4. Guo Q et al.. 2022. Liver sinusoidal endothelial cell expressed vascular cell adhesion molecule 1 promotes liver fibrosis.. Front Immunol 13:983255 PMID: 36091042
- 5. Menon SN et al.. 2023. Neflamapimod inhibits endothelial cell activation, adhesion molecule expression, leukocyte attachment and vascular inflammation by inhibiting p38 MAPKα and NF-κB signaling.. Biochem Pharmacol 214:115683 PMID: 37429422
- 6. Rathjen T et al.. 2022. Endothelial Cell Insulin Signaling Regulates CXCR4 (C-X-C Motif Chemokine Receptor 4) and Limits Leukocyte Adhesion to Endothelium.. Arterioscler Thromb Vasc Biol 42(7):e217-e227 PMID: 35652755
- 7. Guerra-Espinosa C et al.. 2024. ICAMs in Immunity, Intercellular Adhesion and Communication.. Cells 13(4) PMID: 38391953
- 8. Kwon YS et al.. 2023. Oleracone F Alleviates Cognitive Impairment and Neuropathology in APPswe/PSEN1dE9 Mice by Reducing the Expression of Vascular Cell Adhesion Molecule and Leukocyte Adhesion to Brain Vascular Endothelial Cells.. Int J Mol Sci 24(3) PMID: 36768379
